Latest News

Amid 2026 vaccine schedule changes, Trump executive order and vaccines spark confusion—see what’s legal, why AAP guides the childhood vaccine schedule.

The approval is supported by clinical data from 2 studies.

Pharmacists play a key role in translating COVID-19 variant surveillance data into patient-centered counseling on vaccine efficacy.

Prioritizing self-care is not optional; it is necessary for ongoing effectiveness and professional satisfaction.

Making cannabidiol water-soluble could reduce dissolution and food-related variability, but improved aqueous behavior has not yet been shown to produce better clinical outcomes.

The FDA's decision makes iberdomide the first approved CELMoD for patients with relapsed/refractory multiple myeloma.

This study strengthens the evidence base supporting current guidelines and may help reverse the recent decline in pediatric antiviral use.

Active surveillance increased from 27% in 2005 to 93% in 2024, reflecting a major shift away from immediate treatment for favorable-risk disease.

Modeling in Canada suggests price drops of up to 70% could make dual glucagon-like peptide-1 (GLP-1) RA/SGLT2 inhibitor therapy the preferred strategy for high-risk patients with type 2 diabetes (T2D).

The warning has prompted new CDC recommendations for prevention and molecular diagnostic testing.

Most medically complex adults can be vaccinated, but determining when and with which product may require additional assessment.

Nearly half of US adults fall short on this essential mineral. Here’s what to recommend.

Inlexzo (gemcitabine intravesical system) reshapes NMIBC care: bladder‑dwelling therapy, J9183 billing, and coordinated pharmacy‑urology safety steps.

The combination also produced a 78.6% complete response rate in heavily pretreated patients with R/R mantle cell lymphoma following BTK inhibitor therapy.

There are specific, appropriate uses of AI that support pharmacy students and residents without compromising the integrity of their own work.

Pharmacy's location-based title reflects an unfinished professional transition that provider status and privileging, not renaming, must complete.

mRNA vaccines are just one of several vaccine platforms available to patients.

Robust reporting and analysis of medication errors allows health care institutions to identify systemic vulnerabilities, revamp workflows, and build a resilient infrastructure.

Timed clinician prompts plus patient reminders boost annual LDCT follow-up to 75%, highlighting workflow fixes that close lung cancer screening gaps.

Phase 3 MajesTEC-9 findings show teclistamab monotherapy significantly improves progression-free survival and overall survival compared with PVd or Kd.

Though COVID-19 is responsible for fewer deaths and less disease burden, it still represents a formidable threat among seasonal respiratory infections.